MAPT and Alzheimer disease: Min Shi et al. [74] investigated p-tau as a salivary biomarker for AD, and analysis of tau protein species, namely p-tau and t-tau, revealed that the p-tau/t-tau ratio of each individual was higher when compared to the healthy control group, which is consistent with the findings of this study.